---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-119551"
form_type: "8-K"
ticker: "APRE"
cik: "0001781983"
company_name: "Aprea Therapeutics, Inc."
filed_at: "2022-11-16T23:59:59+00:00"
generated_at: "2026-06-21T17:39:21.508980+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aprea Therapeutics regains compliance with Nasdaq minimum $10M stockholders' equity requirement

## Summary
- Received deficiency letter on Aug 15, 2022 for failing minimum $10M stockholders' equity rule.
- Based on Q3 2022 10-Q showing equity of ~$26.6M, Nasdaq confirmed compliance regained.
- Listing on Nasdaq Global Select Market continues without risk of delisting.

## SEC filing metadata
- accession: 0001104659-22-119551
- form_type: 8-K
- ticker: APRE
- cik: 0001781983
- company_name: Aprea Therapeutics, Inc.
- filed_at: 2022-11-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781983/000110465922119551/0001104659-22-119551-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781983/000110465922119551/tm2230665d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-119551
- JSON: https://secwatch.observer/filing/0001104659-22-119551.json
- Plain text: https://secwatch.observer/filing/0001104659-22-119551.txt

## Key facts
- Listing & Compliance Notices
  Aprea Therapeutics, Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5450(b)(1)(A)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: stockholders equity
  - Rules: 5450(b)(1)(A)
  source text: set forth in Listing Rule 5450(b)(1)(A) (the “Rule”). Based on the Company’s Form 10-Q for the period ended September 30, 2022, evidencing stockholders’ equity of approximately $26.6 million, the Staff has determined that the Company has regained compliance with the Rule. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant
  evidence_url: https://www.sec.gov/Archives/edgar/data/1781983/000110465922119551/0001104659-22-119551-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.